Stress) Incombivit Vitamin and mineral complex injected, 100 ml Immunostimulants, Vitamin, and mineral, Digestive regulators Structure 1 ml of the drug contains: vitamin A 15000 IU vitamin D 3 7500 IU vitamin E 20 mg vitamin B 1 10 mg vitamin B 2 5 mg vitamin B 3 (nicotinamide) 50 mg vitamin B 4 (choline chloride) 12.5 mg vitamin B 5 (D-panthenol) 25 mg vitamin B 6 3 mg vitamin B 7 (biotin) 0.125 mg vitamin B 9 (folic acid) 0.15 mg vitamin B 12 0.05 mg lysine 7 mg methionine 5 mg copper sulfate 0.1 mg zinc sulfate 0.1 mg manganese sulfate 0.1 mg Description Liquid yellow or light brown, transparent
discontinued CJC-1295 (DAC) Not FDA-approved Feature Phase III Trial Data Tesamorelin Yes (n=816 pooled) Sermorelin No adult Phase III VAT datasets CJC-1295 (DAC) No Feature Visceral Fat Reduction Tesamorelin 15-20% at 26 weeks Sermorelin Not formally studied in RCTs CJC-1295 (DAC) Not formally studied in RCTs Feature Liver Fat Reduction Tesamorelin 32% at 12 months (NAFLD trial) Sermorelin Not studied CJC-1295 (DAC) Not studied Feature Typical Research Dose Tesamorelin 2 mg daily Sermorelin 200-300 mcg nightly CJC-1295 (DAC) 1-2 mg weekly Feature Unique Advantage Tesamorelin Only FDA-approved GHRH with deepest trial evidence Sermorelin Longest historical track record CJC-1295 (DAC) Weekly dosing convenience Tesamorelin is the only GHRH peptide with active FDA approval and validated Phase III visceral-fat data
Choosing between them comes down to medical history, insurance coverage, supply availability, and the side effect profile that fits your life
These access barriers have contributed to the rise of a market for cheaper, compounded GLP-1 products produced by compounding pharmacies and advertised and sold by telehealth platforms, weight loss clinics, and medical spas (Blum, 2023)
